These results suggest that Ang-2 in collaboration with VEGFR-3, but not Ang-2 alone, promotes tumor lymphangiogenesis in OSCC and Ang-2 might promote VEGFR-3-related tumor lymphangiogenesis and lymph node metastasis in patients with OSCC. This evidence concerns the gene FLT4 and neoplasm.